ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

475
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
03 Jul 2018 10:16

Japan & Korea @Smartkarma: Sharp, Activist in Korea, Alpine AGM & Zozo

Sharp offering update: C pref conversion going through Mio Kato, CFA provides an update on the Sharp offering. Sharp Corp (6753 JP) cancelled its...

Logo
204 Views
Share
04 Jun 2018 20:23

Japan & Korea @Smartkarma:  Autos, Toshiba, NTT, JDI, North Korean Détente, and Trump Trade

As these weekly summaries get written on a weekend we look at things on a Friday-to-Friday schedule but things move at a fast pace. Just a week can...

Logo
155 Views
Share
bullishIcure Pharm Inc
02 Jun 2018 11:48

Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race

Icure Pharm Inc (175250 KS) will offer a total of 1,200,000 shares (100% new rights offering) at ₩44,000 - ₩55,000 which gives a market cap of...

Logo
268 Views
Share
28 May 2018 07:10

A Further Study on Celltrion-Celltrion Healthcare Market Cap Spread Movement

Last Friday (May 25) was a huge day for Celltrion Healthcare (091990 KS) which ended the day with a 7.17% gain. What was the main reason behind...

Logo
407 Views
Share
25 May 2018 10:35

FSC Chairman Speaks on Decision Framework

An article in the 24 May issue of BusinessKorea  (link below) reports on a talk given by Financial Services Commission (FSC) Chairman Choi...

Share
x